IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 89 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $76,131,824 | -20.3% | 16,732,269 | +23.3% | 0.00% | -20.0% |
Q2 2023 | $95,503,218 | +13.8% | 13,565,798 | -1.2% | 0.01% | 0.0% |
Q1 2023 | $83,908,832 | -55.4% | 13,733,033 | -53.3% | 0.01% | -16.7% |
Q4 2022 | $188,063,770 | +97.6% | 29,430,950 | +196.3% | 0.01% | 0.0% |
Q3 2022 | $95,150,000 | -26.8% | 9,932,152 | -15.6% | 0.01% | -25.0% |
Q2 2022 | $129,949,000 | +14.0% | 11,770,751 | +71.9% | 0.01% | +33.3% |
Q1 2022 | $113,981,000 | +17.2% | 6,845,726 | +34.4% | 0.01% | +20.0% |
Q4 2021 | $97,238,000 | -10.1% | 5,093,682 | +16.1% | 0.01% | -16.7% |
Q3 2021 | $108,211,000 | +5.5% | 4,388,106 | +11.3% | 0.01% | +20.0% |
Q2 2021 | $102,588,000 | +5.4% | 3,942,673 | +28.2% | 0.01% | -16.7% |
Q1 2021 | $97,375,000 | -27.6% | 3,075,651 | +6.2% | 0.01% | -25.0% |
Q4 2020 | $134,424,000 | +28.8% | 2,897,079 | -8.6% | 0.01% | +14.3% |
Q3 2020 | $104,342,000 | +11.7% | 3,169,561 | -6.9% | 0.01% | 0.0% |
Q2 2020 | $93,403,000 | -29.1% | 3,402,673 | -22.6% | 0.01% | -41.7% |
Q1 2020 | $131,659,000 | +10.0% | 4,398,171 | +1.7% | 0.01% | +50.0% |
Q4 2019 | $119,693,000 | +38.2% | 4,324,176 | -9.1% | 0.01% | +33.3% |
Q3 2019 | $86,600,000 | +3.2% | 4,758,219 | +39.1% | 0.01% | 0.0% |
Q2 2019 | $83,904,000 | +117.1% | 3,421,866 | -15.8% | 0.01% | +100.0% |
Q1 2019 | $38,641,000 | -2.5% | 4,063,235 | -9.3% | 0.00% | -25.0% |
Q4 2018 | $39,641,000 | -11.5% | 4,479,252 | +12.5% | 0.00% | +33.3% |
Q3 2018 | $44,806,000 | -9.2% | 3,982,562 | +3.3% | 0.00% | -25.0% |
Q2 2018 | $49,350,000 | +32.6% | 3,855,144 | +75.1% | 0.00% | +33.3% |
Q1 2018 | $37,217,000 | +143.6% | 2,202,281 | +15.3% | 0.00% | +200.0% |
Q4 2017 | $15,281,000 | +94.1% | 1,910,512 | +88.1% | 0.00% | 0.0% |
Q3 2017 | $7,871,000 | +8.0% | 1,015,554 | +2.4% | 0.00% | 0.0% |
Q2 2017 | $7,286,000 | – | 991,391 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,674,299 | $65,948,000 | 5.28% |
Ghost Tree Capital, LLC | 700,000 | $17,262,000 | 5.05% |
Perceptive Advisors | 11,489,772 | $283,337,000 | 4.12% |
Prosight Management, LP | 274,761 | $6,776,000 | 3.73% |
Fairmount Funds Management LLC | 389,588 | $9,607,000 | 3.49% |
Avoro Capital Advisors LLC | 8,500,000 | $209,610,000 | 3.29% |
ACUTA CAPITAL PARTNERS, LLC | 374,495 | $9,235,000 | 3.26% |
Ally Bridge Group (NY) LLC | 406,986 | $10,036,000 | 2.95% |
Parametrica Management Ltd | 146,362 | $3,609,000 | 2.70% |
COMMODORE CAPITAL LP | 362,869 | $8,948,000 | 2.36% |